Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation, Restricted Stock and Stock Options (Details) - Schedule of stock-based compensation

v3.23.1
Stock-Based Compensation, Restricted Stock and Stock Options (Details) - Schedule of stock-based compensation - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Schedule Of Stock Based Compensation Abstract    
Research and development expenses $ 384 $ 508
Selling, general and administrative expenses 8,318 1,897
Total stock-based compensation $ 8,702 $ 2,405